Evaluating agitation in critically ill patients using remote video monitoring
A Multi-modal Recognition Model and Efficacy Evaluation for Agitation Behavior in Critically Ill Patients Based on Remote -Ultra-sensitive Detection Wave ---A Multi-center, Open-label, Observational Study
This study is testing a new way to use remote video monitoring to see if it can help doctors better manage agitation in critically ill patients in the ICU.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 580 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 2 sites (Hangzhou, Zhejiang and 1 other locations) |
| Trial ID | NCT06543602 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effectiveness of a multi-modal evaluation monitoring system for detecting agitation in critically ill patients. Participants who are already receiving this monitoring as part of their standard care will be observed over a period of three years. The study focuses on patients at risk of agitation in the ICU, utilizing remote video and ultra-sensitive detection technology to enhance patient care. The goal is to improve the management of agitation in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are critically ill patients aged 18 to 65 who are at risk of agitation and have a RASS score of -2 or higher.
Not a fit: Patients who may not benefit from this study include those with pre-existing neurological or psychiatric conditions, terminal diseases, or those unable to provide consent.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management of agitation in critically ill patients, enhancing their overall care and outcomes.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in utilizing remote monitoring technologies for patient management, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients at risk of agitation in the ICU * Patients with RASS score -2 and above * ≦ 65 years old, ≧ 18 years old Exclusion Criteria: * The affected party refused to participate in this study * Missing/incomplete information * Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives * Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression * Patients with limb impairment and amputation * Spinal cord injury, limb movement/sensory limitations * Patients with pre-existing neurological/psychiatric diseases * Patients with malignant tumors * Patients with infectious diseases * Patients with terminal disease and dying disease * Abnormal behavior due to head injury or craniocerebral disease
Where this trial is running
Hangzhou, Zhejiang and 1 other locations
- the second affiliated hospital, Zhejiang University school of medicine — Hangzhou, Zhejiang, China (Recruiting)
- Sahzu — Hanzhou, Zhejiang, China (Active_not_recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.